OUI THERAPEUTICS INC — Department of Health and Human Services STTR Phase II: 104
OUI THERAPEUTICS INC — STTR Phase II award from Department of Health and Human Services.
Phase II STTR prototype / development signal
- Phase II is where Department of Health and Human Services funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $766,481 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Topic code 104 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $766,481
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- STTR · Phase II
- Topic
- 104
- Solicitation
- PA21-261
- NAICS
- —
- Place of performance
- CT
- Period
- 2023-04-01 → 2026-03-31
Description
ABSTRACT Suicide is a leading cause of death in the US and suicide rates have steadily increased. Despite this, there is a paucity of interventions that reduce suicide ideation and behavior. In this project, we seek to enhance a beta version of our suicide prevention digital therapeutic (developed in phase I) and conduct a randomized controlled trial to evaluate the efficacy of the digital therapeutic for suicide-related outcomes. This project will contribute to our understanding of the use of mobile technology as a suicide prevention tool.